A Policymakers Guide to the Longevity Therapeutics Industry
Our Policymakers’ Guide to Longevity Science is your roadmap to driving meaningful change in healthcare and aging research. Packed with actionable insights, it empowers you to support policies that accelerate breakthroughs in healthspan-extending therapies, reduce age-related diseases, and cut healthcare costs. Together, we can create a future where everyone has the opportunity to live healthier, […]
A Call for a New National Institute for Healthy Longevity and Aging Research (NIHLAR)
The National Institute for Longevity and Aging Research (NIHLAR) is a bold proposal to transform how we tackle aging and age-related diseases. By driving innovation in longevity science, NIHLAR will accelerate breakthroughs that extend healthspan, reduce healthcare costs, and enhance quality of life for millions. Positioned to make the U.S. a global leader in this […]
The California Healthspan Initiative
As California is confronted with an aging population, it is crucial that they take proactive steps to address the stress that this demographic shift will put on housing, healthcare systems, and the associated costs to the public. That is why we at the Alliance for Longevity Initiatives (A4LI) are proud to unveil the California Healthspan […]
The Advanced Approval Pathway for Longevity Medicines (AAPLM)
The Advanced Approval Pathway for Longevity Medicines (AAPLM) seeks to accelerate the development of groundbreaking therapies targeting aging, improving health, reducing healthcare costs, and boosting economic productivity. AAPLM’s provisions include a faster drug approval track, priority review vouchers to incentivize innovation, and patent term extensions to encourage broad therapeutic applications. By aligning economic incentives with […]